Get the Stockscreener App
8.12
1.46%
-0.12
After Hours:
8.12
Kazia Therapeutics Limited Adr Stock (KZIA) Forecast
The Kazia Therapeutics Limited Adr (KZIA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $3.5638, representing a -56.11% decrease from the current price of $8.12. The highest analyst price target is $6.0465, and the lowest is $1.0812.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month KZIA Price Target
Average 7.4656
(-8.06% Downside)
Is Kazia Therapeutics Limited Adr (KZIA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 45.65 | Neutral |
| STOCH(9,6) | 37.75 | Neutral |
| STOCHRSI(14) | 2.6572 | Buy |
| MACD(12,26) | 0.0499 | Sell |
| ADX(14) | 21.19 | Neutral |
| William %R | -75.51 | Neutral |
| CCI(14) | -59.67 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
8.4265
Sell
|
8.5674
Sell
|
| MA20 |
9.2994
Sell
|
8.6822
Sell
|
| MA50 |
7.9349
Buy
|
7.8918
Buy
|
| MA100 |
5.8656
Buy
|
7.6016
Buy
|
| MA200 |
10.40
Sell
|
9.3668
Sell
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, KZIA could be considered a Moderate Sell, with 17 technical analysis indicators signaling 5 Buy signals, 7 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on KZIA, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 45.65 indicates that KZIA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 37.75 indicates that KZIA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 2.6572 indicates that KZIA is oversold. This suggests that KZIA price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 21.19 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -59.67 indicates that KZIA is still oversold but not to an extreme extent.
Long-term KZIA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Kazia Therapeutics Limited Adr financial reports and earnings history, Kazia Therapeutics Limited Adr (KZIA) stock could reach $2.3518 by 2030, $1.2706 by 2040 and $0.1999 by 2050. See the projected annual prices until 2050 of the Kazia Therapeutics Limited Adr stock below:
- Kazia Therapeutics Limited Adr (KZIA) is expected to reach an average price of $0.3116 in 2035, with a high prediction of $0.5092 and a low estimate of $0.3708. This indicates an $-96.16% rise from the last recorded price of $8.12.
- Kazia Therapeutics Limited Adr (KZIA) stock is projected to chart a bullish course in 2040, with an average price target of $1.0485, representing an $-87.09% surge from its current level. The forecast ranges from a conservative $1.0991 to a sky-high $1.2706.
- Our analysts predict Kazia Therapeutics Limited Adr (KZIA) to jump -60.34% by 2045, soaring from $3.0869 to an average price of $3.2206, potentially reaching $3.0894. While $3.0869 is the low estimate, the potential upside is significant.
- Kazia Therapeutics Limited Adr (KZIA) stock is expected to climb by 2050, reaching an average of $0.2999, a $-96.31% jump from its current level. However, a wide range of estimates exists, with high and low targets of $0.1999 and $0.2665, respectively, highlighting the market's uncertainty.
Kazia Therapeutics Limited Adr Stock (KZIA) Year by Year Forecast
Kazia Therapeutics Limited Adr Stock (KZIA) Price Forecast for 2025
Kazia Therapeutics Limited Adr Stock (KZIA) is expected to reach an average price of $3.2997 in 2025, with a high prediction of $6.4287 and a low estimate of $0.1708. This indicates an -59.36% fall from the last recorded price of $8.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| September, 2025 | $4.2465 | $1.0812 | $6.0465 | -47.70% |
| October, 2025 | $5.2487 | $3.1749 | $6.4287 | -35.36% |
| November, 2025 | $4.6825 | $4.334 | $5.2795 | -42.33% |
| December, 2025 | $3.8647 | $3.5247 | $4.4894 | -52.41% |
Kazia Therapeutics Limited Adr Stock (KZIA) Price Forecast for 2026
The predicted value for Kazia Therapeutics Limited Adr (KZIA) in 2026 is set at an average of $8.7016. Estimates vary from a peak of $13.85 to a trough of $3.5531, indicating an +7.16% surge from the present price of $8.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $8.1885 | $3.5531 | $13.85 | +0.84% |
| February, 2026 | $7.1622 | $6.8422 | $8.8738 | -11.80% |
| March, 2026 | $8.176 | $6.5391 | $8.5376 | +0.69% |
| April, 2026 | $9.8182 | $7.4014 | $10.77 | +20.91% |
| May, 2026 | $9.602 | $6.6451 | $11.35 | +18.25% |
| June, 2026 | $11.81 | $8.9154 | $13.08 | +45.39% |
| July, 2026 | $7.8679 | $7.328 | $11.79 | -3.10% |
| August, 2026 | $8.7317 | $7.2448 | $10.20 | +7.53% |
| September, 2026 | $7.9039 | $7.6786 | $9.5101 | -2.66% |
| October, 2026 | $7.2877 | $7.0508 | $8.1023 | -10.25% |
| November, 2026 | $9.2214 | $6.9561 | $9.3714 | +13.56% |
| December, 2026 | $9.7337 | $8.3983 | $10.40 | +19.87% |
Kazia Therapeutics Limited Adr Stock (KZIA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Kazia Therapeutics Limited Adr (KZIA) is $5.6035, with a high forecast of $10.74 and a low forecast of $0.4626. This indicates an -30.99% decrease from the last price of $8.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $9.1874 | $7.939 | $10.12 | +13.15% |
| February, 2027 | $9.8512 | $8.8559 | $10.74 | +21.32% |
| March, 2027 | $6.1219 | $5.4084 | $9.7396 | -24.61% |
| April, 2027 | $6.3572 | $5.7581 | $7.4403 | -21.71% |
| May, 2027 | $5.1709 | $4.594 | $6.8456 | -36.32% |
| June, 2027 | $5.1831 | $4.9031 | $6.5878 | -36.17% |
| July, 2027 | $6.3769 | $4.44 | $7.1268 | -21.47% |
| August, 2027 | $6.1307 | $5.7822 | $7.2938 | -24.50% |
| September, 2027 | $4.8229 | $3.736 | $6.2341 | -40.60% |
| October, 2027 | $4.0466 | $3.7966 | $5.1566 | -50.16% |
| November, 2027 | $2.8804 | $2.612 | $3.9051 | -64.53% |
| December, 2027 | $0.6426 | $0.4626 | $2.8989 | -92.09% |
Kazia Therapeutics Limited Adr Stock (KZIA) Price Forecast for 2028
In 2028, Kazia Therapeutics Limited Adr (KZIA) is projected to reach an average price of $0.4418, with a high projection of $0.8787 and a low estimate of $0.00492. This indicates an -94.56% fall from the last price of $8.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.3064 | $0.2479 | $0.7611 | -96.23% |
| February, 2028 | $0.0202 | $0.00985 | $0.5548 | -99.75% |
| March, 2028 | $0.2113 | $0.0114 | $0.2739 | -97.40% |
| April, 2028 | $0.3641 | $0.3691 | $0.3639 | -95.52% |
| May, 2028 | $0.4173 | $0.3791 | $0.3718 | -94.86% |
| June, 2028 | $0.0821 | $0.0579 | $0.327 | -98.99% |
| July, 2028 | $0.0619 | $0.024 | $0.139 | -99.24% |
| August, 2028 | $0.1481 | $0.0112 | $0.3396 | -98.18% |
| September, 2028 | $0.3118 | $0.00492 | $0.3657 | -96.16% |
| October, 2028 | $0.4356 | $0.2403 | $0.8787 | -94.64% |
| November, 2028 | $0.4678 | $0.3109 | $0.6224 | -94.24% |
| December, 2028 | $0.4516 | $0.4016 | $0.6063 | -94.44% |
Kazia Therapeutics Limited Adr Stock (KZIA) Price Forecast for 2029
The 2029 price forecast for Kazia Therapeutics Limited Adr Stock (KZIA) is $1.12 on average, with a high prediction of $2.2326 and a low estimate of $0.00731. This represents an -86.21% decrease from the previous price of $8.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.3438 | $0.1269 | $0.58 | -95.77% |
| February, 2029 | $0.2186 | $0.2111 | $0.4422 | -97.31% |
| March, 2029 | $0.4113 | $0.227 | $0.5429 | -94.93% |
| April, 2029 | $0.1151 | $0.0688 | $0.4882 | -98.58% |
| May, 2029 | $0.1173 | $0.0215 | $0.2475 | -98.56% |
| June, 2029 | $0.0379 | $0.0389 | $0.3641 | -99.53% |
| July, 2029 | $0.0157 | $0.0692 | $0.0583 | -99.81% |
| August, 2029 | $0.114 | $0.0667 | $0.0486 | -98.60% |
| September, 2029 | $0.0712 | $0.1203 | $0.0961 | -99.12% |
| October, 2029 | $0.0671 | $0.116 | $0.1154 | -99.17% |
| November, 2029 | $0.0728 | $0.0256 | $0.1863 | -99.10% |
| December, 2029 | $2.4526 | $0.00731 | $2.2326 | -69.80% |
Kazia Therapeutics Limited Adr Stock (KZIA) Price Forecast for 2030
Kazia Therapeutics Limited Adr Stock (KZIA) is expected to reach an average price of $2.594 in 2030, with a high forecast of $4.7608 and a low forecast of $0.4273. This signifies an -68.05% decrease from the last price of $8.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.7782 | $2.5319 | $2.3518 | -65.79% |
| February, 2030 | $2.6706 | $2.8106 | $2.7794 | -67.11% |
| March, 2030 | $2.7331 | $2.70 | $2.6702 | -66.34% |
| April, 2030 | $2.8856 | $2.9125 | $2.8856 | -64.46% |
| May, 2030 | $1.2412 | $1.4812 | $2.7433 | -84.71% |
| June, 2030 | $1.8736 | $1.8736 | $1.7636 | -76.93% |
| July, 2030 | $2.4208 | $1.7092 | $4.7608 | -70.19% |
| August, 2030 | $0.7517 | $0.7286 | $2.4677 | -90.74% |
| September, 2030 | $0.2841 | $0.5341 | $0.361 | -96.50% |
| October, 2030 | $0.6347 | $0.4273 | $0.5197 | -92.18% |
| November, 2030 | $0.7922 | $0.776 | $0.5579 | -90.24% |
| December, 2030 | $2.0222 | $1.9666 | $1.8447 | -75.10% |
0.24%
3.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):